DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Moehler M, Heo J, Lee HC. et al.
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE).
OncoImmunology 2019;
8 (08) 1615817
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.